C143H160N24O22 — CID 157404547
3-acetyl-1-[[2-(4-tert-butylphenyl)phenyl]methyl]-5-hydroxypyridazin-4-one;1-(2-cyclohexyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;1-(2-cyclopentyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;N-cyclopropyl-5-hydroxy-1-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-4-oxopyridazine-3-carboxamide;1-(2,2-diphenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;5-hydroxy-N-methyl-1-[[1-(4-methylphenyl)cyclopropyl]methyl]-4-oxopyridazine-3-carboxamide;[6-(methylcarbamoyl)-2-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-5-oxopyridazin-4-yl] acetate (PubChem CID 157404547) has the molecular formula C143H160N24O22 and a molecular weight of 2567.00 g/mol. Its IUPAC name is 3-acetyl-1-[[2-(4-tert-butylphenyl)phenyl]methyl]-5-hydroxypyridazin-4-one;1-(2-cyclohexyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;1-(2-cyclopentyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;N-cyclopropyl-5-hydroxy-1-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-4-oxopyridazine-3-carboxamide;1-(2,2-diphenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;5-hydroxy-N-methyl-1-[[1-(4-methylphenyl)cyclopropyl]methyl]-4-oxopyridazine-3-carboxamide;[6-(methylcarbamoyl)-2-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-5-oxopyridazin-4-yl] acetate.
| Compound Name | 3-acetyl-1-[[2-(4-tert-butylphenyl)phenyl]methyl]-5-hydroxypyridazin-4-one;1-(2-cyclohexyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;1-(2-cyclopentyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;N-cyclopropyl-5-hydroxy-1-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-4-oxopyridazine-3-carboxamide;1-(2,2-diphenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;5-hydroxy-N-methyl-1-[[1-(4-methylphenyl)cyclopropyl]methyl]-4-oxopyridazine-3-carboxamide;[6-(methylcarbamoyl)-2-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-5-oxopyridazin-4-yl] acetate |
|---|---|
| PubChem CID | 157404547 |
| Molecular Formula | C143H160N24O22 |
| Molecular Weight | 2567.00 g/mol |
| Exact Mass | 2565.21 |
| IUPAC Name | 3-acetyl-1-[[2-(4-tert-butylphenyl)phenyl]methyl]-5-hydroxypyridazin-4-one;1-(2-cyclohexyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;1-(2-cyclopentyl-2-phenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;N-cyclopropyl-5-hydroxy-1-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-4-oxopyridazine-3-carboxamide;1-(2,2-diphenylethyl)-5-hydroxy-N-methyl-4-oxopyridazine-3-carboxamide;5-hydroxy-N-methyl-1-[[1-(4-methylphenyl)cyclopropyl]methyl]-4-oxopyridazine-3-carboxamide;[6-(methylcarbamoyl)-2-[[1-(3-methylpyrrolo[2,3-b]pyridin-1-yl)cyclopentyl]methyl]-5-oxopyridazin-4-yl] acetate |
| SMILES | CC(=O)c1nn(Cc2ccccc2-c2ccc(C(C)(C)C)cc2)cc(O)c1=O.CNC(=O)c1nn(CC(c2ccccc2)C2CCCC2)cc(O)c1=O.CNC(=O)c1nn(CC(c2ccccc2)C2CCCCC2)cc(O)c1=O.CNC(=O)c1nn(CC(c2ccccc2)c2ccccc2)cc(O)c1=O.CNC(=O)c1nn(CC2(c3ccc(C)cc3)CC2)cc(O)c1=O.CNC(=O)c1nn(CC2(n3cc(C)c4cccnc43)CCCC2)cc(OC(C)=O)c1=O.Cc1cn(C2(Cn3cc(O)c(=O)c(C(=O)NC4CC4)n3)CCCC2)c2ncccc12 |
| InChI | InChI=1S/C23H24N2O3.C22H25N5O4.C22H25N5O3.C20H25N3O3.C20H19N3O3.C19H23N3O3.C17H19N3O3/c1-15(26)21-22(28)20(27)14-25(24-21)13-17-7-5-6-8-19(17)16-9-11-18(12-10-16)23(2,3)4;1-14-11-27(20-16(14)7-6-10-24-20)22(8-4-5-9-22)13-26-12-17(31-15(2)28)19(29)18(25-26)21(30)23-3;1-14-11-27(20-16(14)5-4-10-23-20)22(8-2-3-9-22)13-26-12-17(28)19(29)18(25-26)21(30)24-15-6-7-15;2*1-21-20(26)18-19(25)17(24)13-23(22-18)12-16(14-8-4-2-5-9-14)15-10-6-3-7-11-15;1-20-19(25)17-18(24)16(23)12-22(21-17)11-15(14-9-5-6-10-14)13-7-3-2-4-8-13;1-11-3-5-12(6-4-11)17(7-8-17)10-20-9-13(21)15(22)14(19-20)16(23)18-2/h5-12,14,27H,13H2,1-4H3;6-7,10-12H,4-5,8-9,13H2,1-3H3,(H,23,30);4-5,10-12,15,28H,2-3,6-9,13H2,1H3,(H,24,30);2,4-5,8-9,13,15-16,24H,3,6-7,10-12H2,1H3,(H,21,26);2-11,13,16,24H,12H2,1H3,(H,21,26);2-4,7-8,12,14-15,23H,5-6,9-11H2,1H3,(H,20,25);3-6,9,21H,7-8,10H2,1-2H3,(H,18,23) |
| InChIKey | BNOJYSKLHWTRSU-UHFFFAOYSA-N |
| XLogP | 17.23 |
| TPSA | 619.22 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 33 |
| Heavy Atoms | 189 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2567.00 |
| LogP ≤ 5 | 17.23 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 40 |